Current Vascular Pharmacology · 2015 · 11 citations · 32 references
Life SciencesCardiologyPhysiologyCell SignalingPathophysiologySignal TransductionCardiovascular Molecular PhysiologyCardiovascular PathophysiologyCardiovascular PhysiologyHypertensive Heart DiseaseProtein Kinase CascadesCardiac Hypertrophy SignalingCell Surface Area ExpansionCell Surface Area RegulationCombination TherapyDifferential SignalingErk SignalingExtracellular Signal-regulated Kinase PathwaySurface Area
Extracellular signal regulated kinase½ (ERK1/2) signaling is critical to endothelin-1 (ET-1)-induced cardiomyocyte hypertrophy. This study was to investigate ERK1/2 signaling and hypertrophic response to ET-1 stimulation in cardiomyocytes (CMs) from spontaneous hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). Primary neonatal SHR and WKY CMs were exposed to ET-1 for up to 24 hrs. Minimal basal ERK1/2 phosphorylation was present in WKY CMs, while a significant baseline ERK1/2 phosphorylation was observed in SHR CMs. ET-1 induced a time- and dose-dependent increase in ERK1/2 phosphorylation in both SHR and WKY CMs. However, ET-1-induced ERK1/2 activation occurred much earlier with significantly higher peak phosphorylation level, and stayed elevated for longer duration in SHR CMs than that in WKY CMs. ET-1-induced hypertrophic response was more prominent in SHR CMs than that in WKY CMs as reflected by increased cell surface area, intracellular actin density, and protein synthesis. Pre-treatment with ERK1/2 phosphorylation inhibitor PD98059 completely prevented ET-1-induced ERK1/2 phosphorylation and increases in cell surface area and protein synthesis in SHR and WKY CMs. The specific PI3 kinase inhibitor LY294002 blocked ET-1-induced Akt and ERK1/2 phosphorylation, and protein synthesis in CMs. These data indicated that ERK1/2 signaling was differentially enhanced in CMs, and was associated with increased cardiac hypertrophic response to ET-1 in SHR. ET-1-induced ERK1/2 activation and cardiac hypertrophy appeared to be mediated via PI3 kinase/Akt signaling in SHR and WKY. The differential ERK1/2 activation in SHR CMs by ET-1 might represent a potential target for combination therapy of hypertension.
32
H E Shubeita, Patrick M. McDonough, Adrienne N. Harris et al. · Journal of Biological Chemistry · 1990 · 643 citations · Full text
Julie R. McMullen, Tetsuo Shioi, Li Zhang et al. · Proceedings of the National Academy of Sciences · 2003 · 530 citations · Full text
Akt1 Is Required for Physiological Cardiac Growth
Brian J. DeBosch, Iya Treskov, Traian S. Lupu et al. · Circulation · 2006 · 528 citations · Full text